A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9217046

Cancer 1997 Jul 15 80 2 317-33

Download in:

View as

Triples

General Info

PMID
9217046